# The Effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep Disturbances in Patients After Acute Myocardial Syndrome

Study · id `cardio:ct-nct02451293` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02451293](<https://clinicaltrials.gov/study/NCT02451293>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02451293

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 252 participants.

## Technical summary

Registry record NCT02451293. Randomized; quadruple masking; primary purpose treatment. Start 2016-01-18 (actual); primary completion 2017-08-18 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 252 participants (enrolled count; ClinicalTrials.gov record NCT02451293, source copy `cardio:ctgov-nct02451293-2019-01-15`, retrieved 2026-10-31)
- Started: 2016-01-18 (actual) (ClinicalTrials.gov record NCT02451293, source copy `cardio:ctgov-nct02451293-2019-01-15`, retrieved 2026-10-31)
- Primary completion: 2017-08-18 (actual) (ClinicalTrials.gov record NCT02451293, source copy `cardio:ctgov-nct02451293-2019-01-15`, retrieved 2026-10-31)
- Completion: 2018-07-20 (actual) (ClinicalTrials.gov record NCT02451293, source copy `cardio:ctgov-nct02451293-2019-01-15`, retrieved 2026-10-31)
- Countries: Denmark (ClinicalTrials.gov record NCT02451293, source copy `cardio:ctgov-nct02451293-2019-01-15`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02451293-2019-01-15`, retrieved 2026-10-31)

## The registry's words

- Brief title: The Effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep Disturbances in Patients After Acute Myocardial Syndrome
- Acronym: MEDACIS
- Condition: Depression
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Melatonin (N-acetyl-5-methoxytryptamine)
- Intervention (Drug): Placebo
- Lead sponsor: Zealand University Hospital
- Lead sponsor class: OTHER
- Collaborator: Psychiatric Research Unit, Region Zealand, Denmark
- Collaborator class: OTHER
- Collaborator: University of Copenhagen
- Collaborator class: OTHER
- Collaborator: Pharma Nord
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: Zealand University Hospital (`cardio:org-zealand-university-hospital`)
- Registry lists this organization as a collaborator: University of Copenhagen (`cardio:org-university-of-copenhagen`)
- Registry lists this organization as a collaborator: Pharma Nord (`cardio:org-pharma-nord`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: External validity of randomized clinical trial studying preventing depressive symptoms following acute coronary syndrome (`cardio:pubmed-34145796`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 6c863bfa244b1346d4663cd15ac90995b4bf70a58533e4d4c68a9b210078f463
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
